Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Theresa Matkovits is on the board of Appili Therapeutics, Inc. and Goodcap Pharmaceuticals, Inc. and Chief Development Officer of Matinas BioPharma Holdings, Inc.

In the past she was Chief Operating Officer for Hepion Pharmaceuticals, Inc., Chief Development Officer for Matinas BioPharma Holdings, Inc. and Head-Strategic Planning & Operations at Novartis AG and Vice President of The Medicines Co. (a subsidiary of Novartis AG).

She received an undergraduate degree from Alfred University and a doctorate from the University of Medicine & Dentistry of New Jersey.


Current positions of Theresa Matkovits 
NameTitle Since
Appili Therapeutics Inc.
(Biotechnology & Medical Research)
Independent Director 2018
Matinas BioPharma Holdings, Inc.
(Biotechnology & Medical Research)
Chief Development Officer 2018
Goodcap Pharmaceuticals, Inc. Director -


Holdings of Theresa Matkovits 
NameEquities%Valuation
Matinas BioPharma Holdings, Inc. (MTNB)
(Biotechnology & Medical Research)
00.0000%0 USD
Appili Therapeutics Inc. (APLI)
(Biotechnology & Medical Research)
00.0000%0 USD


Theresa Matkovits: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/24ELON MUSK : In a faceoff with Elon Musk, the SEC blinked
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
03:49pELON MUSK : Twitter investors vote against re-electing Elon Musk ally to board
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
More news


© 2022 People and Ownership :   
Theresa Matkovits : Connections